2023 Was a troublesome yr for your biopharma industry, with several providers downsizing and restructuring their workforces to stay afloat. You will find indications of recovery, as mergers and acquisitions picked up over the pharmaceutical and lifestyle sciences marketplace within the latter Element of 2023 and have continued their upswing https://sites.google.com/view/bio-sites/blog